Moore Capital Management’s GeneDx Holdings WGS Stock Holding History

Moore Capital Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,606	Closed	-$2.66M	–	869
2021 Q3	$2.66M	Buy	+10,606	New	+$3.64M	0.04%	389
2021 Q1	–	Sell	-30,303	Closed	-$11M	–	792
2020 Q4	$11M	Buy	+30,303	New	+$10.6M	0.12%	121

Other funds holding WGS

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

Moore Capital Management's WGS Position: Q4 2021 in Review

Moore Capital Management sold out of GeneDx Holdings (WGS) in Q4 2021, closing a stake of 10,606 shares — an estimated $2.66M sold.

Moore Capital Management first reported a position in WGS in Q4 2020 and held it in 2 quarters. The position peaked at $11M in Q4 2020. 112 funds tracked by Wall St. Rank hold WGS as of Q4 2021.

Moore Capital Management reported no remaining GeneDx Holdings position as of Q4 2021 after selling out during the quarter.
Moore Capital Management sold 10,606 GeneDx Holdings shares in Q4 2021, an estimated $2.66M.
Moore Capital Management first reported a position in GeneDx Holdings in Q4 2020 and held it in 2 quarters.
Moore Capital Management's GeneDx Holdings position peaked at $11M in Q4 2020.
112 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2021.

Based on Moore Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.